CEBP http://www.cancermicroenvironment.tau.ac.il/welcome2009.html Targets
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spencer, D. L.
Right arrow Articles by Walker, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, D. L.
Right arrow Articles by Walker, N. J.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 139-146, February 1999
© 1999 American Association for Cancer Research

Quantitative Analysis of Constitutive and 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Cytochrome P450 1B1 Expression in Human Lymphocytes1

Diane L. Spencer, Scott A. Masten, Karah M. Lanier, Xinping Yang, Jean A. Grassman, Chris R. Miller, Thomas R. Sutter, George W. Lucier and Nigel J. Walker2

Laboratory of Computational Biology and Risk Analysis, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709 [D. L. S., S. A. M., K. M. L., X. Y., J. A. G., C. R. M., G. W. L., N. J. W.], and Division of Toxicological Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205 [T. R. S.]

Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or dioxin) results in a broad spectrum of biological responses, including altered metabolism, disruption of normal hormone signaling pathways, reproductive and developmental effects, and cancer. Cytochrome P450 1B1 (CYP1B1) is a dioxin-inducible gene that is active in the formation of 4-hydroxyestradiol, a potentially genotoxic catechol estrogen. Therefore, the analysis of CYP1B1 in humans may be useful in establishing relationships between dioxin exposure and adverse health effects. In this study, we examined the expression of CYP1B1 in human peripheral blood lymphocytes of unexposed individuals using a quantitative reverse transcription-PCR method. Absolute CYP1B1 RNA levels varied more than 30-fold in uncultured mononuclear cells obtained from 10 individuals. In vitro treatment of mitogen-stimulated lymphocytes with TCDD for 1–5 days of culture resulted in a peak induction of CYP1B1 after 3 days. The induction of CYP1B1 RNA levels after 3 days of culture was dose-dependent, exhibited a maximum response above 10 nM TCDD, and varied greatly among different individuals. However, the half maximal dose required for this induction was similar between individuals and comparable to that observed in the MCF-7 and HepG2 human cell lines. These observations indicate that CYP1B1 exhibits variable constitutive expression and is inducible in vitro by TCDD in human lymphocytes and that the magnitude of induction varies within the population. These data define the suitability of CYP1B1 for use as a mechanistically based biomarker in ongoing molecular epidemiological studies of human populations exposed to dioxins and related chemicals that bind the aromatic hydrocarbon receptor.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. B. Stangeland, F. Canzian, and A. Haugen
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers
Carcinogenesis, June 1, 2008; 29(6): 1164 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Siest, E. Jeannesson, J.-B. Marteau, A. Samara, B. Marie, M. Pfister, and S. Visvikis-Siest
Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
Drug Metab. Dispos., January 1, 2008; 36(1): 182 - 189.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. H. Straub
The Complex Role of Estrogens in Inflammation
Endocr. Rev., August 1, 2007; 28(5): 521 - 574.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Aklillu, S. Ovrebo, I. V. Botnen, C. Otter, and M. Ingelman-Sundberg
Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene
Cancer Res., June 15, 2005; 65(12): 5105 - 5111.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. M. van Duursen, J. T. Sanderson, and M. van den Berg
Cytochrome P450 1A1 and 1B1 in Human Blood Lymphocytes Are Not Suitable as Biomarkers of Exposure to Dioxin-like Compounds: Polymorphisms and Interindividual Variation in Expression and Inducibility
Toxicol. Sci., May 1, 2005; 85(1): 703 - 712.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. B.M. van Duursen, R. Fernandez Canton, T. Kocan, J. T. Sanderson, K. Kieviet, and M. van den Berg
No Effect of CYP1B1 Val432Leu Polymorphism on CYP1B1 Messenger RNA Levels in an Organochlorine-Exposed Population in Slovakia
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 755 - 756.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert
Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation
Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. T. Landi, P. A. Bertazzi, A. Baccarelli, D. Consonni, S. Masten, G. Lucier, P. Mocarelli, L. Needham, N. Caporaso, and J. Grassman
TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident
Carcinogenesis, April 1, 2003; 24(4): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Toide, H. Yamazaki, R. Nagashima, K. Itoh, S. Iwano, Y. Takahashi, S. Watanabe, and T. Kamataki
Aryl Hydrocarbon Hydroxylase Represents CYP1B1, and not CYP1A1, in Human Freshly Isolated White Cells: Trimodal Distribution of Japanese Population According to Induction of CYP1B1 mRNA by Environmental Dioxins
Cancer Epidemiol. Biomarkers Prev., March 1, 2003; 12(3): 219 - 222.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Lin, S.-W. Hu, and T.-H. Chang
Correlation between Gene Expression of Aryl Hydrocarbon Receptor (AhR), Hydrocarbon Receptor Nuclear Translocator (Arnt), Cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and Inducibility of CYP1A1 and CYP1B1 in Human Lymphocytes
Toxicol. Sci., January 1, 2003; 71(1): 20 - 26.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. M. Martinez, C. A. Afshari, P. R. Bushel, A. Masuda, T. Takahashi, and N. J. Walker
Differential Toxicogenomic Responses to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Malignant and Nonmalignant Human Airway Epithelial Cells
Toxicol. Sci., October 1, 2002; 69(2): 409 - 423.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. P. Bofinger, L. Feng, L.-H. Chi, J. Love, F. D. Stephen, T. R. Sutter, K. G. Osteen, T. G. Costich, R. E. Batt, S. T. Koury, et al.
Effect of TCDD Exposure on CYP1A1 and CYP1B1 Expression in Explant Cultures of Human Endometrium
Toxicol. Sci., August 1, 2001; 62(2): 299 - 314.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Dassi, P. Brambilla, S. Signorini, P. Gerthoux, P. Molteni, R. Sala, and P. Mocarelli
Quantification of Aromatic Hydrocarbon Receptor (AHR) and Related Genes by Calibrated Reverse Transcription-PCR in Blood Mononuclear Cells
Clin. Chem., July 1, 2001; 47(7): 1311 - 1314.
[Full Text] [PDF]


Home page
Toxicol SciHome page
T. S. Thurmond and T. A. Gasiewicz
A Single Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Produces a Time- and Dose-Dependent Alteration in the Murine Bone Marrow B-Lymphocyte Maturation Profile
Toxicol. Sci., November 1, 2000; 58(1): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. F. Badawi, E. L. Cavalieri, and E. G. Rogan
Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17{beta}-estradiol in female Sprague-Dawley rats
Carcinogenesis, August 1, 2000; 21(8): 1593 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. C. Krovat, J. H. Tracy, and C. J. Omiecinski
Fingerprinting of Cytochrome P450 and Microsomal Epoxide Hydrolase Gene Expression in Human Blood Cells
Toxicol. Sci., June 1, 2000; 55(2): 352 - 360.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Heidel, K. Holston, J. T.M. Buters, F. J. Gonzalez, C. R. Jefcoate, and C. J. Czupyrynski
Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene
Mol. Pharmacol., December 1, 1999; 56(6): 1317 - 1323.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.